rs186991064
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_181507.2(HPS5):c.825-16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,556,020 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 3 hom. )
Consequence
HPS5
NM_181507.2 intron
NM_181507.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Publications
0 publications found
Genes affected
HPS5 (HGNC:17022): (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 6 protein and may interact with the cytoplasmic domain of integrin, alpha-3. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 5. Multiple transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
HPS5 Gene-Disease associations (from GenCC):
- Hermansky-Pudlak syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
- Hermansky-Pudlak syndrome without pulmonary fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 11-18305509-A-G is Benign according to our data. Variant chr11-18305509-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 262989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00106 (162/152288) while in subpopulation AMR AF = 0.00118 (18/15298). AF 95% confidence interval is 0.000928. There are 1 homozygotes in GnomAd4. There are 79 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS5 | ENST00000349215.8 | c.825-16T>C | intron_variant | Intron 7 of 22 | 1 | NM_181507.2 | ENSP00000265967.5 | |||
HPS5 | ENST00000396253.7 | c.483-16T>C | intron_variant | Intron 6 of 21 | 1 | ENSP00000379552.3 | ||||
HPS5 | ENST00000438420.6 | c.483-16T>C | intron_variant | Intron 6 of 21 | 1 | ENSP00000399590.2 | ||||
HPS5 | ENST00000531848.1 | c.483-16T>C | intron_variant | Intron 6 of 10 | 5 | ENSP00000431758.1 |
Frequencies
GnomAD3 genomes AF: 0.00106 AC: 161AN: 152170Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
161
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00133 AC: 334AN: 250618 AF XY: 0.00129 show subpopulations
GnomAD2 exomes
AF:
AC:
334
AN:
250618
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00146 AC: 2051AN: 1403732Hom.: 3 Cov.: 23 AF XY: 0.00143 AC XY: 1003AN XY: 701952 show subpopulations
GnomAD4 exome
AF:
AC:
2051
AN:
1403732
Hom.:
Cov.:
23
AF XY:
AC XY:
1003
AN XY:
701952
show subpopulations
African (AFR)
AF:
AC:
9
AN:
32190
American (AMR)
AF:
AC:
63
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
AC:
348
AN:
25788
East Asian (EAS)
AF:
AC:
0
AN:
39334
South Asian (SAS)
AF:
AC:
42
AN:
84874
European-Finnish (FIN)
AF:
AC:
1
AN:
53158
Middle Eastern (MID)
AF:
AC:
9
AN:
5658
European-Non Finnish (NFE)
AF:
AC:
1435
AN:
1059800
Other (OTH)
AF:
AC:
144
AN:
58348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
83
166
248
331
414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00106 AC: 162AN: 152288Hom.: 1 Cov.: 32 AF XY: 0.00106 AC XY: 79AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
162
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
79
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
7
AN:
41552
American (AMR)
AF:
AC:
18
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
53
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
77
AN:
68030
Other (OTH)
AF:
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3476
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.